文献速递眼底病与葡萄膜炎

新生血管性年龄相关性黄斑变性纤维化的综述

Review of Fibrosis in Neovascular Age-Related Macular Degeneration.
PubMed 文献 · Am J Ophthalmol · 2022-09-24

本文为系统综述与Meta分析,纳入观察性研究和随机对照试验,报告新生血管性年龄相关性黄斑变性(nAMD)中纤维化的诊断与定义、流行病学、危险因素及视力结局;纤维化患病率在基线、12、24、60个月分别为13%、32%、36%、56%,伴纤维化眼的最佳矫正视力较无纤维化眼更差。

要点

  • 纤维化患病率在基线、12、24、60个月分别为13%、32%、36%、56%。
  • 5年时约60%的纤维化负荷在治疗第一年内已存在,纤维化发展以最初12个月最快。
  • 基线时伴纤维化眼最佳矫正视力较无纤维化眼差18.50个字母,12个月时差异扩大至26.86个字母。

核心结论

  • 需要确定纤维化的有效治疗策略并密切监测高危患者。
  • 需要更多涉及多模态影像的研究以明确纤维化的定义和分级标准。

研究设计与样本

  • 系统综述与Meta分析,依据Cochrane手册和PRISMA指南实施,纳入观察性研究和随机对照试验。

主要发现

  • 纤维化的识别具有挑战性,光相干断层扫描血管成像和偏振敏感光相干断层扫描是多模态影像中的新选择。
  • 纤维化患病率在基线、12、24、60个月分别为13%、32%、36%、56%。
  • nAMD在5年时约60%的纤维化负荷在治疗第一年内已存在;纤维化发展以最初12个月最快,随后随时间减缓。
  • 纤维化的危险因素包括经典型脉络膜新生血管(CNV)、视网膜内液、出血、高反射物质、CNV病灶大小和视网膜厚度;视网膜下液和色素上皮脱离可能具有保护作用。
  • 治疗相关因素包括疾病活动度和诊断时间;基线时伴纤维化眼的最佳矫正视力较无纤维化眼差18.50个字母,12个月时差异扩大至26.86个字母。

关键数值与推荐

  • 纤维化患病率:基线13%、12个月32%、24个月36%、60个月56%。
  • 基线时伴纤维化眼较无纤维化眼最佳矫正视力差18.50个字母,12个月时差26.86个字母。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纤维化的识别具有挑战性。
  • 需要更多涉及多模态影像的研究以明确纤维化的定义和分级标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the diagnosis and definitions, epidemiology, risk factors, and visual outcomes of fibrosis in neovascular age-related macular degeneration (nAMD). DESIGN: Systematic review and meta-analysis. METHODS: The review was performed using the Cochrane Handbook and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Observational studies and randomized controlled trials were included. RESULTS: Identification of fibrosis is challenging. Optical coherence tomography angiography and polarization-sensitive optical coherence tomography represent novel options in multimodal imaging. The prevalence of fibrosis at baseline, 12, 24, and 60 months was 13%, 32%, 36%, and 56%, respectively. Approximately 60% of the fibrosis burden in nAMD at 5 years was present in the first year of treatment. Fibrosis development was highest in the first 12 months and slowed down over time. The risk factors of fibrosis included classic choroidal neovascularization (CNV), intra-retinal fluid, hemorrhage, hyperreflective material, CNV lesion size, and retinal thickness. Sub-retinal fluid and pigment epithelial detachment may be protective. Treatment-associated factors included disease activity and time to diagnosis. At baseline, the best corrected visual acuity in eyes with fibrosis was poorer than in eyes without fibrosis (-18.50 letters); this difference became larger at 12 months despite treatment (-26.86 letters). CONCLUSIONS: There is a need to identify effective treatment strategies for fibrosis and to closely monitor at-risk patients. More studies involving multimodal imaging are required to clarify the definitions and grading criteria for fibrosis.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Cheong KX, Cheung CMG, Teo KYC, et al. Review of Fibrosis in Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2022. PMID: 36162537. doi:10.1016/j.ajo.2022.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。